testosterone

testosterone
Name	Testosterone
Caption	Structural formula of testosterone
System	Endocrine system
Produced by	Leydig cells of the Testis, Theca cells of the Ovary, and the Zona reticularis of the Adrenal cortex
Precursor	Cholesterol
Receptor	Androgen receptor
Cas number	58-22-0

testosterone is a steroidal androgen hormone primarily produced in the Testis and secondarily in the Ovary and Adrenal cortex. It acts through the Androgen receptor to influence development, physiology, and behavior across vertebrate species, and is central to clinical endocrinology, sports medicine, and reproductive health. Research into testosterone intersects with studies at institutions such as Harvard Medical School, Mayo Clinic, Johns Hopkins Hospital, and Karolinska Institutet.

Biochemistry and Synthesis

Testosterone is synthesized from Cholesterol via a multi-step pathway involving enzymes such as CYP11A1, 3β-Hydroxysteroid dehydrogenase, and 17β-Hydroxysteroid dehydrogenase, with key intermediate steroids including Pregnenolone, Progesterone, Dehydroepiandrosterone, and Androstenedione. Steroidogenic acute regulatory protein (StAR) mediates cholesterol transport into mitochondria in Leydig cells, a process studied at centers like National Institutes of Health and University of Cambridge. Peripheral conversion includes aromatization to Estradiol by Aromatase (CYP19A1) in tissues such as Adipose tissue, Brain regions, and the Placenta.

Physiological Roles

In males, testosterone drives prenatal masculinization of the Wolffian duct system and postnatal pubertal changes including spermatogenesis in the Seminiferous tubules and development of Prostate and Penis. In females, ovarian and adrenal-derived testosterone contributes to libido and influences ovarian folliculogenesis within the Ovary and interactions with Follicle-stimulating hormone pathways at institutions like Imperial College London. Testosterone affects bone density through actions on Osteoblasts and Osteoclasts, modulates erythropoiesis in the Bone marrow, and influences central nervous system circuits studied at Massachusetts General Hospital and Max Planck Institute laboratories.

Regulation and Metabolism

Hypothalamic–pituitary–gonadal axis control involves Gonadotropin-releasing hormone neurons in the Hypothalamus, pulsatile secretions of Luteinizing hormone from the Pituitary gland, and feedback by circulating and intratesticular testosterone; dysregulation is evaluated by endocrine services at Cleveland Clinic and University of California, San Francisco. Metabolism includes hepatic conjugation and excretion in bile and urine, with phase I and phase II enzymes (e.g., CYP3A4, UDP-glucuronosyltransferase) studied in pharmacology units at University of Toronto and Stanford University. Binding to sex hormone–binding globulin synthesized in the Liver alters bioavailability; factors such as Thyroid hormone status, Insulin resistance, and therapies influence SHBG levels.

Medical Uses and Therapies

Therapeutic testosterone formulations—injectable esters, transdermal gels, buccal systems, and subcutaneous pellets—are used for male hypogonadism management with guidelines from bodies like the Endocrine Society and American Urological Association. Off-label and performance-enhancing uses intersect with anti-doping rules enforced by World Anti-Doping Agency and sports medicine programs at U.S. Anti-Doping Agency and UK Anti‑Doping. Testosterone is also used in gender-affirming hormone therapy coordinated through clinics such as Fenway Health and academic centers like University of California, Los Angeles.

Health Effects and Risks

Epidemiological and clinical studies at institutions including Oxford University and Columbia University evaluate associations between testosterone and cardiovascular events, with mixed findings on myocardial infarction risk and stroke. Androgen therapy can exacerbate benign prostatic hyperplasia and influence prostate cancer biology studied at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Adverse effects include erythrocytosis, alterations in lipid profiles, and potential impacts on fertility via suppression of spermatogenesis; monitoring protocols are recommended by organizations such as the European Association of Urology.

Measurement and Diagnostic Testing

Measurement methods include immunoassays and mass spectrometry (LC-MS/MS) in clinical laboratories like those at Mayo Clinic Laboratories and Quest Diagnostics for total, free, and bioavailable testosterone. Diagnostic criteria for hypogonadism used by panels from the Endocrine Society, American Association of Clinical Endocrinologists, and endocrine clinics integrate clinical signs, morning serum levels, and repeat testing, often alongside assessment of Luteinizing hormone and Follicle-stimulating hormone to distinguish primary from secondary causes.

Category:Hormones